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Abstract
Background: Nano-scale dendrimers are synthetic macromolecules that frequently used in medical and health
field. Traditional anibiotics are induce bacterial resistence so there is an urgent need for novel antibacterial drug
invention. In the present study seventh generation poly (amidoamine) (PAMAM-G7) dendrimer was synthesized
and its antibacterial activities were evaluated against representative Gram- negative and Gram-positive bacteria.
Methods: PAMAM-G7 was synthesized with divergent growth method. The structural and surface of
PAMAM-G7 were investigated by transmission electron microscopy, scanning electron microscope and
fourier transform infrared. Pseudomonas. aeruginosa (n = 15), E. coli (n = 15), Acinetobacter baumanni (n = 15),
Shigella dysenteriae (n = 15), Klebsiella pneumoniae (n = 10), Proteus mirabilis (n = 15), Staphylococcus aureus
(n = 15) and Bacillus subtilis (n = 10) have been used for antibacterial activity assay. Additionally, representative standard
strains for each bacterium were included. Minimum Inhibitory Concentration (MIC) was determined using microdilution
method. Subsequently, Minimum Bactericidal Concentration (MBC) was determined by sub-culturing each of the no
growth wells onto Mueller Hinton agar medium. The cytotoxicity of PAMAM-G7 dendrimer were evaluated in HCT116
and NIH 3 T3 cells by MTT assay.
Results: The average size of each particle was approximately 20 nm. PAMAM-G7 was potentially to inhibit both Gram
positive and gram negative growth. The MIC50 and MIC90 values were determined to be 2–4 μg/ml and 4–8 μg/ml,
respectively. The MBC50 and MBC90 values were found to be 64–256 μg/ml and 128–256 μg/ml, respectively. The
cytotoxity effect of dendrimer on HCT116 and NIH 3 T3 cells is dependent upon exposure time to and concentration
of dendrimers. The most reduction (44.63 and 43%) in cell viability for HCT116 and NIH 3 T3 cells was observed at the
highest concentration, 0.85 μM after 72 h treatmentm, respectively.
Conclusions: This study we conclude that PAMAM-G7 dendrimer could be a potential candidate as a novel
antibacterial agent.
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Background
Healthcare associated infection (HCAI) presents a major
problem for patient safety and could lead to prolonged
hospitalization, long-term disability, high costs for
patients and their families, and excess deaths [1, 2]. In
spite of the fact that modern medical science faces rapid
advances, HCAIs still represent a worldwide public
health issue and cause a significant additional financial
burden for the health system. The amount of annual
financial lost due to HCAIs for Europe and USA are 7
billion euro and 6.5 billion dollars, respectively [1, 3].
Multidrug-resistant (MDR) bacteria are reported as the
main responsibility for treatment failure [4]. Methicillin
resistant Staphylococcus aureus [5], extended-spectrum
beta-lactamase-producing E. coli [6], carbapenem resis-
tant Acinetobacter buamanii [4], and Pseudomonas aeru-
ginosa [7] are the most important MDR’s which are
associated with these infection.
Among Shigella species, S. dysenteriae is of particular
importance, because: (1) S. dysenteriae produces the Shiga
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toxin and causes severe infections; (2) S. dysenteriae is
associated with large dysentery epidemics in developing
countries; and (3) S. dysenteriae strains isolated worldwide
are often MDR, with plasmid-mediated resistance to
commonly used antimicrobials such as trimethoprim-
sulfamethoxazole, ampicillin, tetracycline and chloram-
phenicol [8, 9]. Therefore, increment in the number of
nosocomial infection by strains of MDR, the discovery
and development of novel antibacterial agents, particularly
those with structures and mechanisms of action different
from traditional antibiotics, and a low potential to induce
antibiotic resistance, are needed more than ever in the
control and treatment of HCAIs. Compared to bulk mate-
rials, Nanoparticles (NPs) may be strategically advanta-
geous as active antimicrobial agents, since NPs are
excellent adsorbents, catalysts, and sensors due to their
large surface area and high reactivity [10]. In addition,
current antibiotics generally targets three organs consists
of: cell wall, translation machinery and DNA replication
system [11]. Unfortunately, each one of these modes of
actions is susceptible to bacterial resistance. Various simu-
lation processes such as production of reactive oxygen
species, electrostatic interaction with the cell membrane,
ion release, internalization and etc. contribute to NPs
mode of action [12]. Cationic nano dendrimers have
emerged as promising novel antibiotic agents in recent
years [13, 14]. Dendrimers are monodispersed, well-
defined highly branched macromolecule, which exhibit an
exponential increase in functional groups of each
generation. Dendrimers have a highly branched three-
dimensional architecture with spaces between the
branches and since these empty spaces can accept guest
molecules, various size of particle can be encapsulated by
dendrimers [14, 15]. Due to the aforementioned proper-
ties, dendrimers have attracted great interest in exploring
their potential biomedical applications such as drug
delivery, gene transfection, and imaging [16, 17]. Recent
research activities in this area include the study of anti-
microbial activities of dendrimer derivatives. In most
cases, biologically active agents can be encapsulated in the
interior or, more often, tethered on the periphery of the
dendrimers, therefore these dendrimers serve as carriers
of biologically active agents. PAMAM dendrimers are the
most extensively studied dendrimers. PAMAM dendri-
mers with a wide variety of functional groups at the
periphery have the most antibacterial activity [15, 18].
Their high potency antibacterial activity attributed to the
electrostatic interaction between the cationic dendrimer
and the anionic bacteria cell surface so it can be caused
cell death due to the disruption of lipid bilayer. Thus, den-
drimer biocides may be very beneficial in terms of activity,
localization in specific organs, reduced toxicity, and
increased duration of action [16, 17]. The increasmen of
generation of PAMAM dendrimers is followed by a
double increase in the number of functional amine groups
in the structure of dendrimer [15, 19]. We designed a con-
ceptional scheme of PAMAM-G7 dendrimer which shows
the number of functional amino groups in each generation
(Fig. 1a). The structure of PAMAM-G3 is also displayed
in Fig. 1b.
Regarding the fact that bacteria cause hospital infec-
tions, also considering the MDR bacteria, evaluation
of antibacterial properties of PAMAM dendrimers
and taking the advantage of their ability as an
a b
Fig. 1 a conceptional scheme of PAMAM-G7 dendrimer; b structure of PAMAM-G3 dendrimer
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antibacterial and antiseptic can be a research priority.
Present study aimed to determine antibacterial prop-
erties of PAMAM-G7 dendrimer using disc diffusion,
broth microdilution (MIC and MBC determination)
methods. To our knowledge, this is the first report
on the inherent high antibacterial PAMAM-G7
dendrimer which is not modified with common anti-
bacterial agents. Overall, all of the dominant bacteria
which are the main cause of HCAIs are investigated
in current study.
Methods
Bacterial strains
In this study 8 bacterial species including Pseudomonas
aeruginosa (n = 15), E. coli (n = 15), Acinetobacter bau-
manni (n = 15), Shigella dysenteriae (n = 15), Klebsiella
pneumoniae (n = 10), Proteus mirabilis (n = 15), Staphylo-
coccus aureus (n = 15) and Bacillus subtilis (n = 10) were
selected. These bacteria have been isolated from clinical
specimens and identified by conventional microbiological
tests. Additionally, E. coli ATCC 25922, P. aeruginosa
ATCC 27853, A. baumannii ATCC 17957, S. dysenteriae
ATCC 13313, K. pneumoniae ATCC 1705, P. mirabilis
ATCC 29906, S. aureus ATCC 25923 and B. subtilis
ATCC 23857 were used as selected standard strains.
Synthesis and characterization of poly (amidoamine)-G7
Dendrimer
Ethylenediamine (10 ml) was dissolved in 40 ml etha-
nol in a 1-l round-bottomed flask. Methyl acrylate
(112 ml) was added at 40 °C and stirred for 30 h in
the presence of nitrogen exposure. The Excessive me-
thyl acrylate was removed under vacuum condition
room temperature. A Michael addition between the
amine and the acrylate yielded a product bearing four
terminal methyl ester groups, defined as the G0.5
PAMAM. Subsequently, ethylenediamine (1.04 gmol)
was dissolved in ethanol, was added to the G0.5
PAMAM. Then, a product bearing four terminal
amino groups was obtained and defined as the G1
PAMAM, after stirring for 48 h in the presence of
nitrogen and removing excess reactants by vacuum
distillation, seventh generation PAMAM dendrimers
was synthesized by repeating the above cycle [20].
The chemical formula of PAMAM-G7 is C5102H10208
N2042O1020, molecular weight equal to 116,493 g/mol
and the number of terminal amine groups is 512.
The molecular structure has clarify by Fourier trans-
form infrared (FTIR, TENSOR 27 FTIR spectrometer,
Bruker, Germany). Briefly, The samples were mixed with
potassium bromide (KBr) powder and then the mixtures
were made into pellet under high pressure. The sample
pellet was scanned from 400 to 4000 cm−1. Pure KBr
acted as blank. The Morphology and size distribution of
PAMAM-G7 were analyzed by using transmission elec-
tron microscopy (TEM, Philips CM 30) and scanning
electron microscope (SEM, Philips, XL30). For the TEM
investigations, the samples were dispersed in ethanol
and deposited by placing two drops of nanoparticle sus-
pension onto carbon-covered copper-grids, followed by
drying at room temperature. The structure of dendrimer
was analyzed by scanning electron microscopy (SEM,
Philips, XL30). The samples were prepared by mounting
them on double sided carbon tape and coated with a
thin layer of gold before imaging by sputtering method.
Antibacterial activity assay
The antibacterial activity of PAMAM-G7 dendrimer was
determined by using disc diffusion method against clin-
ical and standard bacterial strains as listed above. The
MIC and MBC of the agents were determined by micro
dilution method according to CLSI procedure [21].
Disc diffusion method
An overnight bacterial culture with the turbidity
comparable to 0.5 Mc Farland turbidity standard was
prepared. The surface of a Mueller Hinton agar plate
(4 cm diameter) was cultured uniformly with a sterilized
cotton swab. Dried filter paper discs (6 mm in diameter)
containing 0.025, 0.25, 2.5 and 25 μg/disc were placed
on the plate. Then, plates were incubated 24 h at 37 °C.
The antibacterial activity was determined as the diam-
eter of growth inhibition zone. In each plate a blank disc
without the PAMAM-G7 was used as quality control.
MIC and MBC testing
MIC testing was carried out by using a microdilution
method based on the method recommended by the
Clinical Laboratory Standards Institute [21]. 2-fold
serial dilutions of PAMAM-G7 dendrimer were pre-
pared in sterile Mueller Hinton Broth (MHB) for a
testing concentration range of 1–256 μg/ mL. Then
100 μL from each dilution was transferred into the
well of a microtiter plate and inoculated with 5 μL of
standardized (1.5 × 107 CFU/ mL) bacterial suspen-
sion. The microtiter plates were then incubated
aerobically at 37 °C for 20–22 h, and the lowest con-
centration of the agent that inhibited visible growth
was recorded as the MIC. One well was used as a
positive control for the all tested samples (only
media, inoculum, no PAMAM-G7). Furthermore, an-
other well was used as a negative control (only
media, no inoculum, no PAMAM-G7).
MBC was determined by sub-culturing 10 μL of broth
from wells with no visible growth on nutrient agar
plates. The number of colonies on agar were counted on a
light board and compared to negative controls (only media,
inoculum, no PAMAM-G7). The lowest concentration of
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PAMAM-G7 that killed 99.9% of the original inoculum
was considered as MBC.
Cytotoxicity assay
To analyze the cytotoxicity effect, we used MTT assay
on HCT116 and NIH 3 T3 cells [22] (human intestinal
cancer cell line) which were purchased from the Pasteur
Institute Cell Bank of Iran (http://ncbi.pasteur.ac.ir/).
Briefly, 5000 cells suspended in 96-well plates diluted in
100 μL RPMI 1640 media (Invitrogen, Carlsbad, CA)
which were supplemented with 10% heat-inactivated
fetal bovine serum (FBS, Invitrogen, Carlsbad, CA), and
100 mg/mL penicillin-streptomycin (Invitrogen, Carls-
bad, CA) at 37 °C in a humidified atmosphere containing
5% CO2. After 24 h that all cells attached to the baseline,
100 μL of medium containing different concentration of
PAMAM-G7 (0.043, 0.086, 0.17, 0.34, 0.515, 0.686 and
0.85 μM) were added to each determined well and incu-
bated in above conditions for 48 h and 72 h. After these
incubation, 20 μL containing 5 mg/ml MTT were added
to the wells and incubated again for 4 h. During this
time, the MTT (yellow tetrazolium salt) was enzymati-
cally converted into the purple formazan precipitate by
viable cells that the concentration of formazan shows
the proportional of viable cells. Subsequently, all
medium was aspirated from the cells, then added 150 μl
DMSO to dissolve the formazan participates. Finally,
absorbance was detected at 490 nm wavelength by
ELISA plate reader. Controls were incubated for 48 and
72 h as a negative control and 0.002% benzalkonium
chloride incubated for 30 min as a positive control.
Statistical analysis
Statistical analysis of data was performed using the
Mann-Whitney U test analysis and Analysis of Variance
(ANOVA). Statistical significance was assumed at
P < 0.05. Every experiment was repeated at least three
independent times.
Results
The FTIR spectra of PAMAM-G7 dendrimer NPs
were shown in Fig. 2. FTIR analysis of PAMAM-G7
NPs confirmed the existence of characteristic amides,
terminal amino and etc. The data in Table 1 show
the corresponding functional groups of the wave-
lengths indicated in Fig. 2.
According to the FTIR spectra, the double peaks of
NH2 groups are located at 3200–3500 cm
−1 (NH
stretching) and additional peaks at 1000–1350 and
1500–1630 cm−1 correspond to C–N stretching and
NH bending, respectively. The amide A band
(3407 cm−1) originates from a combination of amide
II stretching and NH in-plane bending vibrations of
the PAMAM-G7. Furthermore, the protonated carboxylic
Fig. 2 FTIR spectra of PAMAM-G7
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acids is characterized by absorption bands corresponding
to a carbonyl stretch (C = O) between 1690 and 1750 cm
−1, and C–OH vibrations between 1200 and 1300 cm−1.
Upon deprotonation, the vibrational mode of C = O be-
comes coupled to that of the other deprotonated oxygen
and its energy shifts to a lower energy level. This gives rise
to an asymmetric stretching feature between 1550 and
1660 cm−1. The C–OH band also shifts to higher energies
upon deprotonation, giving rise to a symmetric COO−
mode between 1300 and 1420 cm−1 as can be seen from
the FTIR spectra. The TEM images of the PAMAM-G7
dendrimer NPs is shown in Fig. 3 PAMAM-G7 NPs were
shown to have a spherical shape with a mean diameter
size of 20 nm. Figure 4 shows SEM image of the
PAMAM-G7 NPs. The SEM image demonstrates that
PAMAM-G7 NPs are nearly spherical. It also displays
multi-layered -like structure, which has smaller spherical
substructures. The results of different concentrations of
PAMAM-G7 dendrimer effect on isolated bacteria and
standard strains (using disc diffusion method) are shown
in Tables 2 and 3, respectively. According to the obtained
results, PAMAM-G7 dendrimer actively inhibited the
growth of isolated Gram-negative and Gram-positive bac-
teria and standard strains. However, the antibacterial
activity of PAMAM-G7 on the isolated bacteria was less
than that on the standard strains.
It was also a statistically significant difference (p‹0.05).
The most of sensitivity related to P. mirabilis ATCC
29906, S. dysenteriae ATCC 13313 and S. aureus ATCC
25923 at concentration of 25 (μg/disc) PAMAM-G7 with
zone of inhibition 36, 32 and 31 mm, respectively. In
addition, the least sensitivity is related to A. baumannii
at 25 (μg/disc) concentration of dendrimer with 13 mm
zone of inhibition. The concentration of 0.025 (μg/disc)
dendrimer had no effect on the studied bacteria, except
P. mirabilis and S. aureus.
The MIC50 and MIC90 values for all selected
bacteria were determined 2–4 μg/ml and 4–8 μg/ml
respectively (Table 4). The MBC50 and MBC90 values
were found to be 64–256 μg/ml and 128–256 μg/ml,
respectively (Table 5). The highest MIC50 and MIC90
values for the clinical isolates were 4 and 8 μg/ml,
Table 1 Band position of PAMAM-G7 spectrum
Band position(cm−1) Assignment
1032.56 C–O stretching vibration
1654.91 C = O stretching (amide I)
1546.25 N-H bending/C-N stretching (amide II)
1462.78 H-C-H scissor
1365.41 H-C-H asymmetric
2828.57and 2942.15 C-H stretching
3407.84 cm−1and
3280
N-H stretching mode of amine I and
amide groups
Fig. 3 TEM Image of the PAMAM-G7 at different magnifications
Fig. 4 SEM Image of the PAMAM-G7
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respectively (Table 4). This was found in E. coli, A.
baumannii, P. aeruginosa and S. aureus isolates.
Table 4 also shows that the least amount of MIC50
and MIC90 were related to S. dysenteriae and P. mir-
abilis (2 μg/ml). Table 5 shows that the highest MBC50
and MBC90 values were related to E. coli, P. aeruginosa
and S. aureus (256 μg/ml). Moreover, it can be seen
from Table 5 that the least amount of MBC50 and
MBC90 with 64 and 128 μg/ml, respectively, are of the
bacteria S. dysenteriae. In addition, the MIC and MBC
of the standard bacteria were also studied. MIC was
found to be 4 μg/ml for E. coli ATCC 25922, A.
baumannii ATCC 17957, P. aeruginosa ATCC27853, S.
aureus ATCC 25923 and 2 μg/ml for K. pneumoniae
ATCC 49131, S. dysenteriae ATCC 13313, P. mirabilis
ATCC 29906 and B. subtilis ATCC 23857. Besides, MBC
for E. coli ATCC 25922, A. baumannii ATCC 17957, P.
aeruginosa ATCC27853, S. aureus ATCC 25923 and K.
pneumoniae ATCC 49131 was 128 μg/ml and for S. dys-
enteriae ATCC 13313, P. mirabilis ATCC 29906 and B.
subtilis ATCC 23857 was seen to be 64 μg/ml.
The profiles of cytotoxicity of PAMAM-G7 against
HCT116 and NIH 3 T3 cells after 48 and 72 h treatment
are shown in Figs. 5 and 6, respectively.
Figures 5 and 6 also indicate that, by the increase of
concentration and exposure time to PAMAM-G7 den-
drimer, cytotoxicity gradually increases. Moreover, statis-
tical results of ANOVA showed that in the exposure
times of 48 and 72 h, the cytotoxicity of PAMAM-G7
dendrimer in all the concentrations and towards both
cell lines was significantly increased in comparison to
the negative control (P < 0.05). So, by the increase of
PAMAM-G7 dendrimer concentration from 0.043 to
0.85 μM, cell viability (HCT116) declined after 48 and
72 h from 86.93 to 70.66% and 82.8 to 55.37%, respect-
ively. Also for NIH 3 T3 cells in the same conditions,
cell viability declined after 48 and 72 h from 87.63 to
68.5% and 83.9 to 57%, respectively. However, there are
relatively low cytotoxicity effects of PAMAM-G7 with
different concentrations towards HCT 116 and NIH
3 T3 cells during 48 and 72 h, where no IC50 value was
obtained. Also, in the range of MIC value the cytotox-
icity of PAMAM-G7 on both cell lines was relatively
low.
Discussion
Today modern hospitalization is the occurrence of noso-
comial or healthcare acquired infections caused by MDR
pathogens [23]. PAMAM dendrimers have been investi-
gated for their biological applications, but antibacterial
activity has not been extensively explored [17, 24]. In
this work, we used disc diffusion and broth microdilu-
tion (MIC and MBC determination) methods to assess
the antibacterial activity of PAMAM-G7 against eight
most common human pathogens isolated from clinical
specimens, as well as standard strains. S. aureus is a
microorganism causing a wide range of infections from
local infections of skin and soft tissue to pneumonia and
endocarditis [25]. A. baumannii is an important human
pathogen causing hospital-acquired infections, such as
ventilator associated pneumonia, bacteremia, meningitis,
urinary tract, and wound infections [26]. E. coli strains
are responsible for several forms of diarrheal disease
[27] and meningitis in neonates [28]. P. aeruginosa is
Table 2 The mean and confidence interval for inhibition zone diameter of isolated bacteria VS different PAMAM-G7 dendrimer
concentrations
Dendrimer
concentration,
μg/disc
Zone of inhibition, mm, [Mean (CI)]
E. coli A.baumannii K. pneumoniae S. dysenteriae P. aeruginosa P. mirabilis B. subtilis S. aureus
0.025 0 0 0 0 0 10 (8.16, 11.84) 0 10 (8.16, 11.84)
0.25 0 0 17 (16.08, 17.92) 0 0 19 (16.23, 21.44) 9 (8.08, 9.92) 11 (8.56, 13.44)
2.5 0 0 19 (18.08, 19.92) 14 (12.16, 15.84) 0 22 (19.56, 24.44) 9 (7.4, 10.6) 11 (7.8, 14.2)
25 22 (20.4, 23.6) 13 (11.6, 14.4) 27 (24.56, 29.44) 30 (27.56, 32.44) 24 (21.23, 26.77) 33 (31.4, 34.6) 18 (16.4, 19.6) 22 (19.56, 24.44)
Table 3 The mean and confidence interval for inhibition zone diameter of standard strains VS different PAMAM-G7 dendrimer
concentrations
Dendrimer
concentration,
μg/disc
Zone of inhibition, mm, [Mean (CI)]
E. coli
ATCC 25922
A. baumanniiATCC
7,957
K. pneumoniae
ATCC 49131
S. dysenteriae
ATCC 13313
P. aeruginosa
ATCC27853
P. mirabilis
ATCC 29906
B. subtilis
ATCC 23857
S. aureus
ATCC 25923
0.025 0 0 0 0 0 12 (10.6, 12.7) 0 12 (10.6, 13.41)
0.25 0 10 (9, 10.9) 20 (16.77, 23.33) 15 (13.4, 16.6) 0 21 (18.7, 22.58) 9 (7.59, 10.41) 13 (12, 13.9)
2.5 10 (9, 10.9) 14 (13, 14.9) 21 (20.08, 21.92) 20 (18.6, 20.72) 9 (8.08, 9.92) 24 (22.2, 25) 10 (8.9, 11) 19 (17.6, 20.4)
25 26 (25, 26.9) 20 (17.2, 22.8) 29 (28.08, 29.92) 32 (30.6, 33.4) 25 (22.7, 26.5) 36 (35.08, 36.9) 22 (21, 22.9) 31 (30.47, 31.53)
Gholami et al. BMC Infectious Diseases  (2017) 17:395 Page 6 of 11
inherently resistant to drugs because of its less perme-
able cell wall and a variety of efflux pumps [29]. K. pneu-
moniae can be found commonly in humans and animals’
mouth, skin, and intestines as an opportunistic patho-
gen, frequently causing pneumonia, infection of the
urinary tract, and soft tissues [30].
The infections caused by S. dysenteriae and Proteus
mirabilis had a serious clinical problem. S. dysenteriae is
the cause of brisk and deadly epidemics and pose major
health problems in the poorest populations. Alternative
therapeutic strategies are necessarily in search due to
the emergence of MDR in Shigellae [31]. Antibacterial
properties of PAMAM-G7 dendrimer was checked also
against B. subtilis. B. subtilus is not a common HCAI or-
ganism, but it was used as a representative for spore-
forming bacteria [32]. The size of the inhibition zone
clearly shows that with increasing concentrations of the
PAMAM-G7 NPs, the surrounding zone of the discs is
expanded (Tables 2 and 3). The results of this study
showed that very low concentrations (0.025 μg/disc) of
the dendrimer PAMAM-G7 inhibits the growth of the P.
mirabilis and S. aureus isolates (Tables 2 and 3). The
study carried out by Izanloo et al. [33], by disc diffusion
method on the effect of dendrimer PAMAM-G4 on E.
coli, Enterobacter cloacae, B. subtilis and S. aureus,
concluded that concentration of 0.05 μg/disc has no ef-
fect on these bacteria and it was shown that the antibac-
terial effect of PAMAM-G4 takes place in higher
concentrations. Izanloo et al. [34], in another study
which was carried out by disc diffusion method and was
aimed to evaluate the effect of PAMAM-G4 dendrimer
on Klebsiella oxytoca, P. mirabilis and P. aeruginosa, has
showed that concentrations of 0.5, 5 and 50 μg/disc of
PAMAM-G4 has no effect on these selected bacteria.
Probably, the higher antibacterial effect of PAMAM-G7
dendrimer in comparison to lower generation dendri-
mers can be attributed to high density, ordered, hyper
branching structure, high spatial void between branches,
large number of terminal functional groups and rela-
tively large molecular size of PAMAM-G7 [24]. These
characteristics lead to high surface area in dendrimer
PAMAM-G7 which causes higher activity of dendrimers
in surface of culture and higher efficiency at lower con-
centrations. Figure 4 shows a SEM image of dendrimer
PAMAM-G7. Because of their multi-layered structures
with high purity, they can trap and absorb many micro-
bial agents. Dendritic structures known as dendriform
with progressive structure are illustrated in this figure.
Too many branches of this dendriform lead to increase
in the dendrimer surface area therefore they absorb mi-
crobes on their surface. On the other hand, nano holes
created between branches trap biological agents and
destroy them. But most importantly, it is the number of
terminal amine groups, which for generation 4 is 64,
while the number of terminal amine groups for
PAMAM-G7 is 512 (http://www.dendritech.com/
pamam.html) [35]. These functional groups are adsorbed
on the bacterial cell surfaces, diffused through the cell
wall, bonded to cytoplasmic membrane and release
electrolytes such as potassium ions and phosphate from
the cell, also nucleic materials such as DNA and RNA
due to disruption and disintegrate of the cytoplasmic
membrane. Therefore it is proposed that the antibacter-
ial property of dendrimers is mediated by disrupting the
bacterial outer and inner membrane by terminal amine
groups [17, 36].
According to MIC or MBC values (Tables 4 and 5), it is
clear that PAMAM-G7 has antibacterial effects and can
be used as antibacterial agent. Previous studies have been
shown that these antibacterial agents cause bacterial cell
membrane damage, spatial deformation, degradation of
bacterial enzymes, damage of chromosome and bacteria
cell wall damage [15, 37]. This character refers to end
amine groups in dendrimer structure which interact with
negative charge of membrane or microorganism
cytoplasm, causing bacterial cell wall damage and finally,
inactivation of bacteria [16]. Figure 2 shows the FTIR
spectra of PAMAM-G7 dendrimer. As shown, 9 peaks are
detectable at 1032 cm−1, 1365 cm−1, 1462 cm−1, 1546 cm
Table 4 MIC of the PAMAM-G7 dendrimer for isolated bacteria
Bacteria spp MIC (μg/ml) n(%) MIC
50
MIC
901 2 4 8
E. coli 10 (66.7) 5 (33.3) 4 8
A. baumannii 9 (60) 6 (40) 4 8
K. pneumoniae 7 (70) 3 (30) 2 4
S. dysenteriae 5 (33.3) 10 (66.7) 2 2
P. aeruginosa 12 (80) 3 (20) 4 8
P. mirabilis 3 (20) 12 (80) 2 2
B. subtilis 1 (10%) 9 (90) 4 4
S. aureus 10 (66.6) 5 (33.3) 4 8
Table 5 MBC of the PAMAM-G7 dendrimer for isolated bacteria
Bacteria spp MBC (μg/ml) n(%) MBC
50
MBC
9064 128 256
E. coli 3 (20) 12 (80) 256 256
A. baumannii 9 (60) 6 (40) 128 256
K. pneumoniae 7 (70) 3 (30) 128 256
S. dysenteriae 9 (60) 6 (40) 64 128
P. aeruginosa 2 (13) 13 (87) 256 256
P. mirabilis 3 (20) 12 (80) 128 128
B. subtilis 1 (10) 9 (90) 128 128
S. aureus 5 (33) 10 (67) 256 256
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−1, 1654 cm−1, 2828 cm−1, 2942 cm−1 3280 cm−1 and
3407 cm−1which the last peak is related to N-H stretching
vibration of primary amine. Other main band positions,
based on wavenumber, and their assignments are pre-
sented in Table 1.
Thus, the PAMAM-G7 dendrimer is an efficient anti-
bacterial agent for both Gram-negative and Gram-
positive bacteria. Chen et al. [38], observed the antibac-
terial effect of polypropyleneimine dendrimer modified
with quaternary ammonium groups on Gram-positive
and Gram-negative bacteria. Likewise, Xue. et al. and
Charles. et al., have shown that amino-terminated
PAMAM-G2 and G3 dendrimers possess significant
antibacterial effects on MDR strains [14, 15].
As shown in Tables 2, 3, 4 and 5, the E. coli, P. aerugi-
nosa, A. baumannii and S. aureus had a higher resist-
ance than other studied bacteria. Probably the effect of
lower concentrations of dendrimer PAMAM-G7 on the
bacteria such as E. coli, P. aeruginosa, A. Baumannii and
S. aureus than other target bacteria can be due to intrin-
sic resistance of these bacteria [5, 39, 40].
Also, the cytotoxicity of PAMAM-G7 was investigated
on HCT 116 and NIH 3 T3 cell lines (mammalian cells).
The obtained data (Figs. 5 and 6) show that by increas-
ing both concentration and exposure time the cytotoxity
effect on target cells increases.
Mukherjee et al. [22] indicated different generations
(G4, G5 and G6) of PAMAM dendrimers with variety of
Fig. 5 PAMAM-G7 cytotoxicity to HCT116 cells measured by MTT survival assay in 48 h and 72 h with 0.002% benzalkonium chloride (bac) as the
positive control. Percent survival of HCT116 cells upon treatment with PAMAM-G7 at various concentrations is based on an untreated control. The
data show the mean from two separate experiments (48 h and 72 h) with three replicates per condition, and the error bar represents a
standard deviation
Fig. 6 PAMAM-G7 cytotoxicity to NIH 3 T3 cells measured by MTT survival assay in 48 h and 72 h with 0.002% benzalkonium chloride (bac) as the
positive control. Percent survival of NIH 3 T3 cells upon treatment with PAMAM-G7 at various concentrations is based on an untreated control.
The data show the mean from two separate experiments (48 h and 72 h) with three replicates per condition, and the error bar represents a
standard deviation
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doses which increasing dose and generation of these
dendrimers cause decrease in the percentage of healthy
and early apoptotic cell which increasing dose and
generation of these dendrimers cause decrease in the
percentage of healthy and early apoptotic cell. At high
concentrations, PAMAM can lead to the formation of
nanoscale holes in eukaryotic membranes [22, 41, 42].
Highly branched cationic polymers permeate eukaryotic
membranes better than linear molecules, such as LL-37
[42], so PAMAM dendrimers are more toxic for
eukaryotic cells. This property of branched polymers has
been widely used in foreign gene or drug transfaction in
eukaryotic cells [17]. The charge density on the polymer
also plays an important role in permeability [42]. After
72 h of treatment at the highest concentration of
PAMAM-G7 (0.85 μM), 55.37 and 57% of HCT116 and
NIH 3 T3 cells survived, respectively (Figs. 5 and 6). The
value of obtained MIC50, MIC90 (2–4 and 4–8 μg/ml,
respectively) and MIC for standard strains (2 μg/ml) for
both Gram-positive and Gram-negative bacteria,
showed, PAMAM-G7 at relatively lower concentrations,
has high toxic effect on both Gram-negative and Gram-
positive bacteria.
However in 0.086 μM (10 μg/ml) PAMAM-G7 and
after 48 and 72 h, 84 and 77% of HCT 116 cells were
survived, respectively (Fig. 5). Also in same condition
85.61 and 79.24% of NIH 3 T3 cells were survived,
respectively (Fig. 6).
Furthermore the most important attachment is great
toxicity of PAMAM-G7 on Gram-negative and Gram
positive bacteria. However PAMAM-G7 has relatively
low toxicity on HCT 116 and NIH 3 T3 cells. To further
elucidate this observation, it was noted that the polyca-
tionic PAMAM molecules prefer to bind to bacteria cells
that carry a higher density of negative charges on their
surfaces rather than eukaryote cell lines.
Initial electrostatic interaction, followed by further in-
teractions, including hydrophobic interactions between
the dendrimers and cell membrane, are shown to be ne-
cessary to cause cell lysis, since it has been shown that
surfaces presenting a high density of amino groups have
no marked effect on the membrane of the attached
bacteria [17, 42].
However, various studies have shown that, PAMAM
dendrimers show relatively high toxicity against various
eukaryotic cells. But the notable point is that, most studies
regarding the use of PAMAM dendrimers, are in the field
of drug delivery and gene transfection. The high amount
of dendrimers is required on drug and gene delivery so,
such studies indicate the high toxic effect of PAMAM
dendrimers on eukaryotic [43, 44], the cytotoxicity of
PAMAM dendrimers, often investigates in higher concen-
trations. In a study the toxic effect of different PAMAM
dendrimers (G3, 3.5, 4, 4.5, and) generations on HepG2
and DU145 cell lines was investigated. It indicate, HepG2
were less sensitive than DU145 cells with IC50
values ≥ 402 μM (PAMAMs) and ≤13.24 μM (PAMAMs)
for DU145 [45]. In another study the cytotoxicity of
various PAMAM dendrimers (G4, G5, G6) generations on
HaCaT and SW480 cells was measured by MTT assay,
after 24 h exposure it was found that, EC50 concentra-
tions for PAMAM G4, G5 and G6 in SW480 cells were
equal to 1.44, 0.37 and 1.16 μM, respectively, and for
HaCaT cells were equal to 1.02, 1.07, and 3.21 μM,
respectively [22].
Conclusion
The results of this study showed PAMAM-G7 dendrimer
has good antibacterial activity against both Gram-positive
and Gram-negative bacteria. We think this compound can
be implemented as an antiseptic and disinfectant agent in
health sections. In addition, in the MIC value range, the
cytotoxicity effect of PAMAM-G7 on HCT 116 and NIH
3 T3 cells was relatively lower. So, PAMAM-G7 could be
an excellent candidate as new class of antibacterial com-
pounds for control of bacterial infections. However to
achieve this goal further studies are needed.
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